title: [Percutaneous transluminal coronary angioplasty in acute myocardial infarction. A prospective controlled study].
abstract: In the present study we compared the outcome of primary percutaneous coronary angioplasty (PTCA) (PTCA without prior or concomitant administration of thrombolytic drugs) in 82 consecutive patients with acute myocardial infarction (AMI) with the outcome of 82 AMI patients, who were treated with intravenous thrombolysis. The thrombolysis patients were prospectively matched to the angioplasty patients regarding age, sex, duration of symptoms and infarct localisation. The in-hospital mortality was 3.7% in the PTCA group versus 4.9% in the thrombolysis group. Thrombolysis-treated patients had increased use of diuretics and ACE-inhibitors as compared to PTCA-treated patients. The mean ejection fraction was 52 +/- 11% in the PTCA group versus 47 +/- 10% (p = 0.01) in the thrombolysis group. We conclude that initial Danish experience with primary PTCA is promising, and that this treatment may favourably affect the outcome of acute myocardial infarction.
authors.affiliation: Arhus Universitetshospital, Skejby Sygehus, hjertemedicinsk afdeling B.
authors.forename: L
authors.initials: L
authors.lastname: Thuesen
authors.forename: K
authors.initials: K
authors.lastname: Rasmussen
authors.forename: H R
authors.initials: HR
authors.lastname: Andersen
authors.forename: T V
authors.initials: TV
authors.lastname: Nielsen
authors.forename: A B
authors.initials: AB
authors.lastname: Villadsen
authors.forename: H H
authors.initials: HH
authors.lastname: Hansen
authors.forename: A P
authors.initials: AP
authors.lastname: Schroeder
authors.forename: S E
authors.initials: SE
authors.lastname: Husted
authors.forename: T T
authors.initials: TT
authors.lastname: Nielsen
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000075202:Contraindications; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D011446:Prospective Studies; D015912:Thrombolytic Therapy